Matthew Loberg
@maloberg.bsky.social
MD/PhD trainee at Vanderbilt University School of Medicine. Grad student in Vivian Weiss's lab studying thyroid cancer progression and the tumor microenvironment. Future pathologist!
I had so much fun presenting at AACR this week! Thanks to all of our collaborators for helping with this project! And special thanks to @ltkagohara.bsky.social for helping with the spatial data analysis.
Congratulations to @maloberg.bsky.social for the excellent work presented at AACR 2025!! Big thanks to our incredible research collaborators!
May 1, 2025 at 6:08 PM
I had so much fun presenting at AACR this week! Thanks to all of our collaborators for helping with this project! And special thanks to @ltkagohara.bsky.social for helping with the spatial data analysis.
Reposted by Matthew Loberg
A new issue of Cell is out, featuring the 4 winners of the Rising Black Scientists Awards. Their essays bring hope, inspiration and reinforce the importance of equity in science. Do take a moment to check them out: www.cell.com/cell/current
@cp-cell.bsky.social
@cp-cell.bsky.social
February 6, 2025 at 7:41 PM
A new issue of Cell is out, featuring the 4 winners of the Rising Black Scientists Awards. Their essays bring hope, inspiration and reinforce the importance of equity in science. Do take a moment to check them out: www.cell.com/cell/current
@cp-cell.bsky.social
@cp-cell.bsky.social
We are excited to share our recent pre-print exploring cancer-associated fibroblast (CAF) phenotypes as thyroid cancers progress from treatable well-differentiated tumors to highly lethal anaplastic thyroid cancer! @vivianweiss.bsky.social @hartheat.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations
Thyroid cancer progression from curable well-differentiated thyroid carcinoma to highly lethal anaplastic thyroid carcinoma is distinguished by tumor cell de-differentiation and recruitment of a robus...
www.biorxiv.org
February 6, 2025 at 5:14 PM
We are excited to share our recent pre-print exploring cancer-associated fibroblast (CAF) phenotypes as thyroid cancers progress from treatable well-differentiated tumors to highly lethal anaplastic thyroid cancer! @vivianweiss.bsky.social @hartheat.bsky.social
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...